Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Eur Rev Med Pharmacol Sci ; 20(4): 636-41, 2016.
Article in English | MEDLINE | ID: mdl-26957264

ABSTRACT

OBJECTIVE: Crescent literature data demonstrated a role of adipokines in immune responses, particularly leptin is involved in wide spectrum of pro-inflammatory functions. Several evidences suggested that leptin is able to inhibit T regulatory cells proliferation and function in vitro models. In the present study, we investigate the relationship between leptin and circulating T regulatory cells (Tregs) in patients affected by systemic lupus erythematosus (SLE). PATIENTS AND METHODS: 13 SLE patients and 11 healthy controls were enrolled. Metabolic syndrome and cardiovascular parameters were evaluated. Serum leptin levels were detected by commercial ELISA kit and circulating regulatory T cells were determined by FACS analysis as CD4+CD25highFOP3+ lymphocytes. RESULTS: Metabolic syndrome, defined by ATPIII criteria, was more prevalent in SLE compared to controls (38.4% vs. 0%, p = 0.04), as well as arterial hypertension (38.4% vs. 0%, p = 0.04). We did not find significant differences in mean leptin levels among SLE and controls (13.13 ± 1.51 ng/ml vs. 9.48 ± 8.67 ng/ml, p = 0.6). Mean Tregs percentage of total CD4 were 1.27 ± 0.9 in SLE vs. 2.8 ± 1.2 in healthy controls (p = 0.001). We found a negative correlation between leptin levels and Tregs percentage of total CD4 in SLE patients (r = 0.4, p = 0.01). CONCLUSIONS: Our results suggest a role of leptin in the regulation of circulating T regulatory cells amount in human SLE.


Subject(s)
Leptin/blood , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/diagnosis , T-Lymphocytes, Regulatory/metabolism , Adipokines/blood , Adult , Biomarkers/blood , CD4-Positive T-Lymphocytes/metabolism , Cell Proliferation/physiology , Cohort Studies , Female , Humans , Lymphocyte Activation/physiology , Male , Metabolic Syndrome/blood , Metabolic Syndrome/diagnosis , Middle Aged
2.
Int J Immunopathol Pharmacol ; 27(4): 645-51, 2014.
Article in English | MEDLINE | ID: mdl-25572746

ABSTRACT

A growing body of evidence presents a link between chronic inflammatory rheumatic diseases and atherosclerosis. To evaluate subclinical carotid atherosclerosis in an elderly group of patients with primary Sjögren syndrome compared with a control group matched for age, sex, ethnicity and cardiovascular risk factors, we enrolled 18 patients with Primary Sjögren Syndrome (mean age 65 ± 5.93 SD) and 18 mild Ostheoarthritic patients (mean age 66 ± 5.94 SD) from the outpatient department of Rheumatology, University “Campus Bio-Medico, Rome, Italy, matched for age, sex, ethnicity and cardiovascular risk factors. A duplex Doppler sonographic study of carotids was performed in order to evaluate intima-media thickness (IMT), stiffness and haemodynamic parameters [resistivity and pulsatility indices (RI and PI, respectively)]. No significant difference was found between primary Sjögren syndrome and control patients in IMT, stiffness and haemodynamic parameters. The lack of significant difference in subclinical atherosclerosis between elderly primary Sjögren syndrome and control matched patients, indicates that traditional cardiovascular risk factors, immunologic alterations and chronic inflammation do not influence the progression of vascular damage in the carotid circulation of patients with median disease duration of 6.5 years.


Subject(s)
Carotid Artery Diseases/diagnostic imaging , Sjogren's Syndrome/diagnostic imaging , Ultrasonography, Doppler, Duplex/methods , Aged , Aged, 80 and over , Carotid Artery Diseases/pathology , Carotid Artery Diseases/physiopathology , Carotid Intima-Media Thickness , Female , Hemodynamics , Humans , Male , Sjogren's Syndrome/pathology , Sjogren's Syndrome/physiopathology , Vascular Stiffness
3.
Curr Med Chem ; 20(27): 3370-96, 2013.
Article in English | MEDLINE | ID: mdl-23746272

ABSTRACT

Complex molecular and cellular mechanisms are involved in the pathway of liver fibrosis. Activation and transformation of hepatic stellate cells (HSCs) are considered the two main reasons for the cause and development of liver fibrosis. The peroxisome proliferator-activated receptors (PPARs) belonging to the family of ligand-activated transcription factors play a key role in liver homeostasis, regulating adipogenesis and inhibiting fibrogenesis in HSCs. Normal transcriptional function of PPARs contributes to maintain HSCs in quiescent phase. A reduced expression of PPARs in HSCs greatly induces a progression of liver fibrosis and an increased production of collagen. Here, we discuss role and function of PPARs and we take into consideration molecular factors able to reduce PPARs activity in HSCs. Finally, although further validations are needed, we illustrate novel strategies available from in vitro and animal studies on how some PPARs-agonists have been proved effective as antifibrotic substances in liver disease.


Subject(s)
Liver/metabolism , Peroxisome Proliferator-Activated Receptors/metabolism , Animals , Antifibrinolytic Agents/therapeutic use , Hepatic Stellate Cells/metabolism , Humans , Liver Cirrhosis/drug therapy , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , PPAR alpha/agonists , PPAR alpha/metabolism , PPAR delta/agonists , PPAR delta/metabolism , PPAR gamma/agonists , PPAR gamma/metabolism , PPAR-beta/agonists , PPAR-beta/metabolism , Peroxisome Proliferator-Activated Receptors/chemistry
4.
Int J Immunopathol Pharmacol ; 25(1): 275-80, 2012.
Article in English | MEDLINE | ID: mdl-22507341

ABSTRACT

We describe the case of a 45-year-old woman who had drawn our attention for some recent episodes of transient global amnesia that, upon further examination, resulted from ischemic events caused by multiple arterial thrombosis (bilateral internal carotid occlusion, significant stenosis of the right external carotid, mild stenosis of the right vertebral artery, right anterior cerebral artery occlusion and severe stenosis of the anterior descending coronary artery) due to primary antiphospholipid syndrome. Revascularisation of either carotid was not attempted. A percutaneous intervention in the anterior descending coronary artery stenosis was performed successfully. Due to severe arterial thrombosis, the patient was discharged with only duplex antiplatelet treatment and subcutaneous anticoagulant therapy, since immunotherapy is not indicated in primary APS. The occurrence of transient global amnesia should raise the suspicion of APS.


Subject(s)
Amnesia, Transient Global/etiology , Antiphospholipid Syndrome/complications , Female , Humans , Middle Aged
5.
Int J Immunopathol Pharmacol ; 25(4): 1157-65, 2012.
Article in English | MEDLINE | ID: mdl-23298507

ABSTRACT

Neuropsychiatric manifestations are not rarely associated with systemic lupus erythematosus (SLE). Magnetic resonance angiography and positron emission tomography can provide excellent images of cerebral perfusion and metabolism whereas information is still lacking on a possible diagnostic role of ultrasound. In this study we aim to assess whether duplex sonography of neck and intracranial vessels may be useful in distinguishing patients with and without neuropsychiatric SLE (NPSLE). Neck and transcranial duplex sonography was performed by a single operator on 33 women affected by SLE (mean age +/- SD: 47.69+/-8.17 years) and on 15 healthy control subjects. Nineteen patients presented NPSLE. Pulsatility and resistivity indices (PI and RI) were automatically calculated by the ultrasound instrument in internal carotid (ICA) and middle cerebral artery (MCA), on both sides, according to standard methods. No significant haemodynamic differences were found in mean and median PI and RI values of ICA and MCA comparing SLE with NPSLE patients and with healthy control subjects. No correlation was found between MCA and ICA parameters in the same group of patients. Duplex sonography of cerebral vessels is unable to distinguish SLE and NPSLE patients. Heterogeneity of causes in the pathogenesis of NPSLE and the different vascular adaptation of cerebral macrocirculation as opposed to cerebral microcirculation may represent possible reasons that explain the inability of ultrasound to differentiate SLE patients from NPSLE patients.


Subject(s)
Echoencephalography , Lupus Erythematosus, Systemic/diagnostic imaging , Lupus Vasculitis, Central Nervous System/diagnostic imaging , Adult , Aged , Carotid Artery, Internal/physiopathology , Cerebral Arteries/physiopathology , Female , Humans , Male , Middle Aged
7.
Int J Immunopathol Pharmacol ; 22(3): 763-72, 2009.
Article in English | MEDLINE | ID: mdl-19822093

ABSTRACT

The aim of our study is to evaluate portal and hepatic hemodynamic changes after N-acetylcysteine infusion in patients with systemic sclerosis. In an open-label study 40 patients with systemic sclerosis (SSc) were treated with 15 mg/kg/hour intravenous N-acetylcysteine for 5 consecutive hours in a single day. Hepatic flow volume, congestion index, portal flow volume, resistance index and pulse rate index were measured in each subject before and after infusion. In all patients mean hepatic flow volume (HFV) and mean portal flow volume (PFV) values after the five-hour infusion with NAC increased not significantly. In 22 selected patients with active capillaroscopic pattern, modified Rodnan Total Skin Score (mRTSS)<18 and mild-moderate score to vascular domain of disease severity scale (DSS), mean HFV increased significantly when compared with mean HFV of 18 SSc patients with late capillaroscopic pattern, mRTSS>18 and severe-end stage score to vascular domain of DSS. The results of our study demonstrate that NAC is able to increase HFV and total liver perfusion after a single infusion in SSc patients with low disease activity and severity scores.


Subject(s)
Acetylcysteine/administration & dosage , Hepatic Artery/drug effects , Liver Circulation/drug effects , Portal Vein/drug effects , Scleroderma, Systemic/drug therapy , Vasodilator Agents/administration & dosage , Adult , Capillaries/drug effects , Capillaries/physiopathology , Female , Hepatic Artery/diagnostic imaging , Hepatic Artery/physiopathology , Humans , Infusions, Intravenous , Male , Microscopic Angioscopy , Middle Aged , Portal Vein/diagnostic imaging , Portal Vein/physiopathology , Pulsatile Flow/drug effects , Scleroderma, Systemic/diagnostic imaging , Scleroderma, Systemic/physiopathology , Severity of Illness Index , Treatment Outcome , Ultrasonography, Doppler, Color , Vascular Resistance/drug effects
8.
Lupus ; 18(3): 249-56, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19213864

ABSTRACT

Detection of early carotid vascular disease in patients with systemic lupus erythematosus (SLE) is considered mandatory for evaluation of subclinical atherosclerosis (ATS), and various ultrasonographic (US) parameters have been proposed. In the present investigation, 33 SLE and 33 healthy age-matched females have been studied by colour-coded sonography of the common carotid artery, assessing intima-media thickness (IMT), vascular strain (VS), vascular distensibility (VD), vascular stiffness (VSf) and pressure-strain elastic modulus (PSEM) as possible markers of early ATS. Patients with SLE, despite equivalent exposure to "traditional" cardiovascular risk factors, presented a higher mean IMT of the common carotid artery than healthy subjects (0.7 +/- 0.2 mm vs 0.5 +/- 0.1 mm - P < 0.0001). Of the stiffness parameters, patients with lupus showed a mean VSf of 0.72 +/- 0.38 vs 0.54 +/- 0.14 in controls (P < 0.0001) and a mean PSEM of 6.0 +/- 2.8 Pa vs 3.0 +/- 1.4 Pa in controls (P < 0.0001). Mean VS and VD were significantly lower in patients with SLE than in healthy subjects (P < 0.0001). Among individuals with IMT < 0.6 mm, patients with SLE presented more compromised stiffness parameters. IMT was shown to be a useful parameter in the evaluation of vascular damage, even in a "sub-clinical" phase, while stiffness parameters provide additional details regarding endothelial and vessel functional state. Combined evaluation may allow ATS to be detected in the early stages in patients with SLE.


Subject(s)
Atherosclerosis/pathology , Lupus Erythematosus, Systemic/pathology , Tunica Intima/anatomy & histology , Tunica Media/anatomy & histology , Adolescent , Adult , Aged , Atherosclerosis/diagnostic imaging , Blood Flow Velocity , Elastic Modulus , Female , Humans , Lupus Erythematosus, Systemic/diagnostic imaging , Middle Aged , Risk Factors , Severity of Illness Index , Tunica Intima/diagnostic imaging , Tunica Intima/pathology , Tunica Media/diagnostic imaging , Tunica Media/pathology , Ultrasonography , Vascular Diseases/diagnostic imaging , Vascular Diseases/pathology , Young Adult
9.
Eur Rev Med Pharmacol Sci ; 11(3): 171-8, 2007.
Article in English | MEDLINE | ID: mdl-17970233

ABSTRACT

Lupus nephritis is characterized by intrarenal inflammation. Leukocytes trafficking from peripheral blood into affected tissues spaces represent an important factor in the development of many renal diseases. During the past few years has been attributed the crucial role of a family of chemotactic cytokines--the chemokines--in this process. In the course of renal diseases, the infiltration of monocytes/macrophages and T cells into kidneys represent an important role in progressive interstitial fibrosis and the progression of chronic renal failure. In this review, we summarize the in vitro and in vivo data on chemokines and chemokine receptors in kidney diseases, with a special focus on urine chemokine measurement as possible biomarker of human lupus nephritis.


Subject(s)
Chemokines/urine , Lupus Nephritis/urine , Animals , Biomarkers/urine , Chemokines/immunology , Humans , Th1 Cells/immunology , Th2 Cells/immunology
11.
Lupus ; 16(1): 56-8, 2007.
Article in English | MEDLINE | ID: mdl-17283587

ABSTRACT

The antiphospholipid syndrome (APS) is an autoimmune disorder, characterized by a wide spectrum of clinical manifestations. Thromboembolic events, with a greater involvement of extremities veins, are the most common features, and obstruction of abdominal vessels are sporadically reported. We present a singular case of a patient with primary APS (PAPS) that developed a spontaneous splenorenal shunt, secondary to a total portal, mesenteric and splenic vein thrombosis. Spontaneous splenorenal shunt, an uncommon circumstance reported in cirrhotic disease, to the best of our knowledge, has not been previously described in PAPS.


Subject(s)
Antiphospholipid Syndrome/complications , Fistula/etiology , Mesenteric Vascular Occlusion/etiology , Portal Vein/pathology , Renal Veins/pathology , Splenic Vein/pathology , Venous Thrombosis/etiology , Female , Fistula/diagnostic imaging , Genetic Predisposition to Disease , Heterozygote , Humans , Methylenetetrahydrofolate Reductase (NADPH2)/deficiency , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Middle Aged , Protein C Deficiency/complications , Protein S Deficiency/complications , Renal Veins/diagnostic imaging , Splenic Vein/diagnostic imaging , Thrombophilia/etiology , Thrombophilia/genetics , Ultrasonography, Doppler, Color
12.
Prostaglandins Other Lipid Mediat ; 83(1-2): 1-24, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17259068

ABSTRACT

According to current literature, infective processes greatly modify both vascular hemodynamics and anti-oxidant properties of affected tissues, causing a change in homeostasis that regulates the correct functioning of all cells responsible for the physiological and metabolic balance of various organs. As a consequence, the response to the infection that has caused the change is also likely to be weaker and, in the case of septic shock, ineffective. In this review, we will take into consideration these mechanisms and then focus on a group of vasodilator drugs (prostacyclin and its analogs) which, though have been used for over 20 years mainly to treat obstructive vascular diseases, have such hemodynamic and anti-inflammatory properties which prevent homeostatic changes. It is obvious that prostacyclin does not definitively have anti-infective characteristics; however, in association with anti-infective drugs (antibiotics, etc.), the effectiveness of the latter appears improved, at least in some circumstances. Similarly, the fact that prostacyclin and its analogs have a cytoprotective effect on the liver and reduce the ischemia-reperfusion damage following liver transplant is not a novelty and evidence that they improve hepatic hemodynamics suggests their use in those pathologies characterized by possible reduced perfusion or ascertained ischemia of the liver.


Subject(s)
Epoprostenol/metabolism , Sepsis/metabolism , Animals , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Epoprostenol/biosynthesis , Epoprostenol/pharmacology , Humans , Reperfusion Injury , Splanchnic Circulation/drug effects
13.
J Exp Clin Cancer Res ; 25(3): 449-51, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17167987

ABSTRACT

A 76-year-old woman with a history of dyspnoea, weight loss and abdominal pain, was admitted to our Hospital. Sonographic and tomographic examinations showed the presence of a large adrenal gland tumor and the promptly performed adrenalectomy and splenectomy proved that the lesion was an adrenal gland carcinoma infiltrating the spleen. One month after surgical treatment, the patient's general condition dramatically worsened due to development of perirenal abscess and renal infarction; finally, the patient died. In accordance with literature, we decided to only perform adrenalectomy and splenectomy that are the treatment of choice in these cases. In fact, complications are unforeseeable and avoiding the resection of the kidney surely offered the patient a better life quality.


Subject(s)
Adrenal Cortex Neoplasms/surgery , Adrenocortical Carcinoma/surgery , Postoperative Complications/surgery , Adrenal Cortex Neoplasms/complications , Adrenal Cortex Neoplasms/diagnosis , Adrenocortical Carcinoma/complications , Adrenocortical Carcinoma/diagnosis , Aged , Fatal Outcome , Female , Humans
14.
Histopathology ; 48(7): 822-30, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16722931

ABSTRACT

AIMS: To evaluate the cytoplasmic and nuclear expression of hepatic growth hormone receptor (GHR) in different stages (S0, S1, S3 and S4, according to Knodell's classification) of chronic liver disease (CLD) and in hepatocellular carcinoma (HCC). METHODS AND RESULTS: Liver specimens from 31 patients with hepatitis C virus-related CLD, five patients with HCC and nine controls were examined for expression of hepatic GHR by immunohistochemistry with MAb 263. Cytoplasmic and nuclear staining were evaluated as a percentage of positively stained cells. The cytoplasmic expression of GHR was comparable between normal liver and S0 hepatitis, while it progressively decreased in S1, S3 and S4 CLD (P < 0.01). Conversely, nuclear GHR showed increased expression in S3 and S4 CLD (P < 0.05). No differences were observed between HCC and normal liver in terms of GHR immunoreactivity. CONCLUSIONS: This is the first study to show that the subcellular expression of hepatic GHR changes with the progression of CLD. The increase in nuclear expression of GHR with advanced stages of CLD suggests that GH may act directly at the nuclear level to promote hepatocyte proliferation/regeneration.


Subject(s)
Carcinoma, Hepatocellular/pathology , Hepatitis C, Chronic/pathology , Liver Neoplasms/pathology , Liver/pathology , Receptors, Somatotropin/analysis , Adult , Aged , Carcinoma, Hepatocellular/metabolism , Cell Nucleus/chemistry , Cytoplasm/chemistry , Disease Progression , Female , Hepatitis C, Chronic/metabolism , Humans , Immunohistochemistry , Liver/chemistry , Liver Neoplasms/metabolism , Male , Middle Aged
16.
Chemotherapy ; 51(4): 193-6, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16006765

ABSTRACT

The most important species of Cryptosporidium in humans, C. parvum and C. hominis, cause severe and chronic life-threatening gastroenteritis in immunocompromised patients. Despite a certain efficacy shown by passive immunotherapy or by some chemotherapeutic agents (e.g. paromomycin and nitazoxanide), no significant benefit has been demonstrated. The use of highly active antiretroviral therapy (HAART) in persons with the acquired immunodeficiency syndrome drastically reduces the prevalence of Cryptosporidium infection. This result seems to be due to aspartyl protease inhibitors of the human immunodeficiency virus included in HAART, which directly interfere with the life cycle of the parasite. The identification of the C. parvum proteases involved in the host-cell interaction could lead to new therapeutic approaches using specific parasite protease inhibitors in immunocompromised persons.


Subject(s)
Antiretroviral Therapy, Highly Active , Cryptosporidiosis/drug therapy , Immunocompromised Host , Protease Inhibitors/pharmacology , Animals , Aspartic Acid Endopeptidases/antagonists & inhibitors , Cryptosporidiosis/immunology , Cryptosporidium parvum/enzymology , Cryptosporidium parvum/pathogenicity , HIV Infections/complications , HIV Infections/drug therapy , Humans
17.
Curr Pharm Des ; 10(17): 2081-92, 2004.
Article in English | MEDLINE | ID: mdl-15279547

ABSTRACT

Ribavirin is a very broad-spectrum anti-viral agent used clinically to treat infections by Lassa fever virus, respiratory syncytial virus (RSV) and, in combination with Interferon-alpha (IFN-alpha), hepatitis C virus (HCV). Although it was originally synthesized over 30 years ago, the precise mechanisms of its therapeutic activities are still not fully understood. Ribavirin was shown to possess both direct and indirect action mechanisms against several DNA and RNA viruses. These include direct inhibition of viral RNA-dependent RNA polymerases, inhibition of the host inosine monophosphate dehydrogenase, modulation of the host immune response and inhibition of viral capping enzymes. More recently, ribavirin was demonstrated to be able to act as an RNA virus mutagen, increasing mutations in the RNA virus genome and reducing their infectivity. Still the real challenge is to identify which of its biological properties is responsible for the observed clinical efficacy on specific infections. Under this aspect, renewed interest results from its synergistic enhancement of interferon-alpha (IFN-alpha) therapy, which could open the way to develop more powerful anti-HCV compounds. This work purpose is to provide a broad overview of all the recognized ribavirin action mechanisms against HCV, which can possibly also explain its synergistic behavior with IFN-alpha. An overview on the corresponding HCV treatment clinical observations is also provided in the second part of this work.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C/drug therapy , Interferon-alpha/therapeutic use , Ribavirin/therapeutic use , Antiviral Agents/pharmacology , Clinical Trials as Topic , Drug Therapy, Combination , Humans , Interferon-alpha/pharmacology , Ribavirin/pharmacology
18.
Clin Ter ; 154(6): 415-9, 2003.
Article in Italian | MEDLINE | ID: mdl-14994522

ABSTRACT

A 33 years old immunocompromised woman was admitted for a fever of unknown origin during the last five months. She referred a body temperature up to 38.3 degrees C, headache, weakness. The physical examination revealed right homonymous hemianopia, hyperreflexia and Babinski on her right side. A TC scan and a following bioptic specimen showed multiple cerebral tuberculomas. A conventional therapy was started but no significative improvement was observed. She was finally treated with interferon gamma and GM-CSF in addition to the therapy with an important regression of the lesions and significative improvement of the fever and neurological findings.


Subject(s)
Immunocompromised Host , Tuberculoma, Intracranial/drug therapy , Adult , Drug Resistance, Microbial , Female , Humans , Tuberculoma, Intracranial/immunology
19.
Parassitologia ; 44(3-4): 201-2, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12701384

ABSTRACT

We report a case of myiasis of a rectocutaneous fistula in a subject suffering from bone metastases after surgical resection of a neoplastic bladder. The fistula was infested by maggots identified as third-instar larvae of flies belonging to the family Sarcophagidae, genus Sarcophaga. The infestation was neither intestinal nor pseudointestinal; it was probably caused by a fly ovipositing on the fistula of the patient while having wound care at home, even though the possibility that the infestation might have occurred during hospitalization cannot be ruled out.


Subject(s)
Cutaneous Fistula/complications , Myiasis/complications , Postoperative Complications/parasitology , Rectal Fistula/complications , Animals , Bone Neoplasms/secondary , Cutaneous Fistula/parasitology , Diptera/growth & development , Humans , Larva , Male , Middle Aged , Rectal Fistula/parasitology , Urinary Bladder Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...